Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Iradimed (IRMD) over the last 12 years, with Q3 2025 value amounting to 0.2%.

  • Iradimed's Return on Invested Capital rose 100.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.21% for FY2024, which is 100.0% up from last year.
  • Iradimed's Return on Invested Capital amounted to 0.2% in Q3 2025, which was up 100.0% from 0.2% recorded in Q2 2025.
  • Iradimed's 5-year Return on Invested Capital high stood at 0.21% for Q3 2023, and its period low was 0.02% during Q1 2021.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.19% (2022), whereas its average is 0.17%.
  • In the last 5 years, Iradimed's Return on Invested Capital tumbled by -1400bps in 2021 and then skyrocketed by 1300bps in 2022.
  • Over the past 5 years, Iradimed's Return on Invested Capital (Quarter) stood at 0.13% in 2021, then rose by 30bps to 0.17% in 2022, then increased by 15bps to 0.2% in 2023, then dropped by -1bps to 0.2% in 2024, then decreased by 0bps to 0.2% in 2025.
  • Its Return on Invested Capital was 0.2% in Q3 2025, compared to 0.2% in Q2 2025 and 0.2% in Q1 2025.